New Drug
Clinical development of new drug-radiotherapy combinations.
... Before designing an early-phase clinical study, investi- gators must define the proposed treatment in instances of unmet need, and select a registerable end point that the clinical study will pursue. This will inform on ...
16
International Conference on Harmonisation Guidelines for Regulation of Pharmaceutical Impurities in New Drug Substances
... in Drug Substance for Authorities Abbreviated Registration ...in new drug substance is intended to provide guidance for registration applications on the content and qualification of impurities in ...
5
Kluger - The New Drug Crisis.pdfView Download
... developed new policies to treat pain more proactively, approaching it not just as an unfortunate side effect of illness but as a fifth vital sign, along with temperature, heart rate, respiratory rate and blood ...
6
REGISTRATION PROCESS OF GENERIC DRUGS IN USFDA
... generic drug is a pharmaceutical product, usually intended to be interchangeable with a new drug (an innovator product) that is manufactured without a license from the innovator company and marketed ...
6
Notice to applicants for marketing authorizations for proprietary medicinal products in the Member States of the European Community on the use of the new multi-state procedure created by Council Directive 83/570/EEC
... - 5- III" NEW DRUG APPLICATIONS AND ABRIDGED APPLICATIONS The multi-state procedure may be used not only for new drug applications but also for abridged applications submitted pursuant t[r] ...
72
Safety and effectiveness of over-the-counter drugs: The FDA's OTC drug review
... If the ingredients and claims of a product are not in the OTC drug monograph, then the product is not generally recognized as safe and effective and may not be marketed unless a New Drug[r] ...
5
PREFORMULATION NSU (Final).ppt
... Investigation of physico-chemical properties of the new drug compound that could affect drug performance and development of an efficacious dosage form”.. Preformulation commence[r] ...
65
An Update on the Therapeutic Orphan
... and Drug Administration; NDA, new drug application; PDR, Physicians Desk Reference; NME, new molecular entity; AAP, American Academy of Pediat- rics; COD, Committee on Drugs; OPD, orphan ...
8
New targets for an old drug
... this drug in RA, this could present the pharmaceutical industry with a new RA target and open wide opportunities for the search of new drug chemotypes that may be less prone to resis- tance ...
23
FORCED DEGRADATION STUDIES: PRACTICAL APPROACH - OVERVIEW OF REGULATORY GUIDANCE AND LITERATURE FOR THE DRUG PRODUCTS AND DRUG SUBSTANCES
... (≥75% relative humidity), oxidation and photolysis. Testing in solution should also be performed across a wide pH range either as a solution or suspension. These samples are then used to develop a stability-indicating ...
8
Drug Repositioning: Concept, Classification, Methodology, and Importance in Rare/Orphans and Neglected Diseases
... a new chemical entity (NCE) - a molecule not yet described in the literature that has an active portion capable of triggering a physiological/pharmacological action (Branch and Agranat, 2014; FDA, ...the ...
9
Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies
... a new drug sensitivity metric, AUC adjusted for the range of tested concentrations, which allows reconciliation of publicly available heterogeneous pharmacologic data enabling pooled analysis for ...
7
The Paradigm-Shift toward the Next Generation of Drugs
... calibration through negative feedback, evolution, and appearance of phenomena emerging through time. Another crucial concept to account for new drug development is the entropy. The dynamic equilibrium of a ...
29
Phytopharmaceuticals: A new class of drug in India
... a drug on similar lines to synthetic, chemical ...the new draft regulation was not present, Guggulu tablets (for treatment of hypercholesterolemia), Gingko-biloba tablets (to treat temporary loss of ...
11
left over genetics.ppt
... • Selecting ideal traits of existing species. • Creating new drug delivery systems[r] ...
29
The Affordable Prescription Drugs Act: A Solution for Today's High Prescription Drug Prices
... of new essential ...essential drug, whether current prices are fair, Congress’ attitude towards these prices, the drug industry’s justifications for high prices, and presents a rebuttal argument ...
25
New cast for a new era: preclinical cancer drug development revisited
... this drug combination significantly extends survival in tumor-bearing mice (84); however, Infinity Pharmaceuticals halted the phase II clini- cal trial (NCT01130142) because interim analyses revealed infe- rior ...
8
Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences
... ototoxicity and the use of aminoglycosides and capreomycin in TB treatment, but this study only included reports up to June 2014, i.e. before aDSM was recommended. Two publications from the Nigerian PV programme about ...
14
Bioactive Metabolites Obtained from Endophytes Bacterial Isolate
... Genetic diversity is the total number of genetic characteristics in the genetic makeup of a species. It is distinguished from genetic variability, which describes the tendency of genetic characteristics to vary. Genetic ...
13
Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
... Consequently, drug assessment based on eBA may underestimate the potency of inhibitors that display a delayed onset of bacterial ...as drug binding to host plasma proteins and lack of drug ...
11